Literature DB >> 14216643

THE USE OF N-ACETYLCYSTEINE IN THE TREATMENT OF CYSTIC FIBROSIS.

H W REAS.   

Abstract

Entities:  

Keywords:  ACETYLCYSTEINE; ADOLESCENCE; CHILD; CYSTEINE; CYSTIC FIBROSIS; INFANT; INHALATION THERAPY; KLEBSIELLA; LUNG DISEASES; PNEUMONIA; PROTEUS INFECTIONS; PSEUDOMONAS INFECTIONS; PULMONARY EMPHYSEMA; RESPIRATORY FUNCTION TESTS; SPIROMETRY; STAPHYLOCOCCAL INFECTIONS; THORACIC RADIOGRAPHY

Mesh：

Substances：

Year:  1964        PMID： 14216643     DOI： 10.1016/s0022-3476(64)80289-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  4 in total

1.  N-acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium spp.

Authors:  A J De Lucca; T J Walsh; D J Daigle
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

2.  Cystic fibrosis.

Authors:  M B Mearns
Journal:  Arch Dis Child       Date:  1985-03       Impact factor: 3.791

3.  A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis.

Authors:  F Ratjen; R Wönne; H G Posselt; B Stöver; D Hofmann; S W Bender
Journal:  Eur J Pediatr       Date:  1985-11       Impact factor: 3.183

4.  Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis.

Authors:  P H Weller; D Ingram; M A Preece; D J Matthew
Journal:  Thorax       Date:  1980-01       Impact factor: 9.139
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.